Gradiant Corporation
Financials
Valuation Metrics
Gradiant Corporation's Market Cap is ₩1096B. At end of 2025 it was ₩1304B. Ranked #1174 of 2,436 in KR market (top 48%), #616 of 1,649 on KOSDAQ (top 37%), #26 of 47 in Consumer Discretionary Distribution & Retail (top 55%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 109.63B KRW | KR#1,174/2,436 Sec#26/47 |
| Revenue | 3.16T KRW | KR#191/2,436 Sec#7/47 |
| Net Income | -12.70B KRW | KR—/2,436 Sec—/47 |
| Total Assets | 1.80T KRW | KR#314/2,436 Sec#9/47 |
| Net Assets | 713.17B KRW | KR#370/2,436 Sec#14/47 |
| Employees | 63 | KR#1,919/2,436 Sec#33/47 |
| Value | ||
| P/B | 0.15x | KR#48/2,436 Sec#1/47 |
| P/S | 0.03x | KR#12/2,436 Sec#1/47 |
| FCF Yield | -8.61% | KR—/2,436 Sec—/47 |
| Profitability | ||
| ROE | -1.78% | KR#1,604/2,436 Sec#30/47 |
| ROA | -0.71% | KR#1,570/2,436 Sec#28/47 |
| Op. Margin | -0.68% | KR#1,653/2,436 Sec#38/47 |
| Revenue Growth | 12.60% | KR#826/2,436 Sec#13/47 |
| Financial Health | ||
| Debt Ratio | 152.57% | KR#1,222/2,436 Sec#22/47 |
| Total Debt | 160.36B KRW | KR#563/2,436 Sec#19/47 |
| FCF | -9.44B KRW | KR#1,694/2,436 Sec#32/47 |
| Cash | 168.02B KRW | KR#312/2,436 Sec#6/47 |
| Current Ratio | 1.07x | KR#1,741/2,436 Sec#29/47 |
| Dividend | ||
| Div. Yield | 2.18% | KR#859/2,436 Sec#17/47 |
| Div. Growth | 0.00% | KR—/2,436 Sec—/47 |
| Performance | ||
| 1Y Return | -35.03% | KR#1,705/2,436 Sec#29/47 |
| 1M Return | 3.56% | KR#569/2,436 Sec#10/47 |
| From 52W High | -38.49% | KR#693/2,436 Sec#17/47 |
| 1Y MDD | -52.19% | KR#1,023/2,436 Sec#27/47 |
| Trading | ||
| Volume | 26,221 shares | KR#1,731/2,436 Sec#30/47 |
| Foreign Own. | 3.47% | KR—/2,436 Sec—/47 |
| Per Share | ||
| EPS | -2,093 KRW | KR—/2,436 Sec—/47 |
| BPS | 39,046 KRW | KR#293/2,436 Sec#10/47 |
Company Info
Gradient, established in 1997 and listed on KOSDAQ in 1999, entered the healthcare industry in 2014 and completed the incorporation and absorption merger of subsidiaries in 2025. It provides comprehensive management for affiliated companies, B2B e-commerce for industrial goods, bio-healthcare business (including development, research, and distribution of pharmaceuticals and medical supplies), and integrated logistics agency services. Through its health functional food brand Radiewell and inner beauty brand Leanfit, the company focuses on selecting premium ingredients and developing products, pursuing global business expansion. Gradient is headquartered in Gangnam-gu, Seoul.